XXII 22nd Century Group, Inc.
Cigarettes · Nasdaq · SEC CIK 1347858 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-15.5%
TTM net income YoY-79.5%
TTM EPS YoY135.6%
Revenue 3-yr CAGR-24.0%
Net income 3-yr CAGR—
Margins
Gross margin53.6%
Operating margin-76.7%
Net margin-80.0%
FCF margin-43.3%
EBITDA margin-73.7%
Returns
ROE-70.9%
ROA-43.8%
ROIC (approx.)-72.0%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets31.2%
Debt / equity0.00x
Current ratio2.27x
Interest coverage-205.44x
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio-22.7%
Payout ratio—
Capex / revenue4.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $17.59M | $24.38M |
| Cost of revenue | $10.19M | $14.28M |
| Gross profit | $7.40M | $10.10M |
| R&D expense | $688,000 | $1.13M |
| SG&A expense | $7.59M | $10.29M |
| Operating income | -$11.57M | -$13.95M |
| Interest expense | $1.46M | $2.09M |
| Pretax income | -$13.14M | -$15.46M |
| Income tax | -$28,000 | $30,000 |
| Net income | -$5.05M | -$15.16M |
| EBITDA | -$11.09M | -$13.37M |
| EPS (basic) | -52.87 | -45,711.05 |
| EPS (diluted) | -52.87 | -45,711.05 |
| Weighted avg. shares (diluted) | 184,067 | 557 |
| Balance sheet | ||
| Cash & equivalents | $7.15M | $4.42M |
| Receivables | $3.59M | $1.70M |
| Inventory | $4.33M | $2.02M |
| Current assets | $17.63M | $11.52M |
| PP&E, net | $2.44M | $2.77M |
| Intangibles | $6.22M | $5.72M |
| Total assets | $27.02M | $21.67M |
| Current liabilities | $7.27M | $9.96M |
| Short-term debt | — | $1.50M |
| Long-term debt | $708,000 | $5.17M |
| Total debt | $708,000 | $6.67M |
| Total liabilities | $8.53M | $17.66M |
| Shareholders' equity | $15.76M | $4.01M |
| Net debt | -$6.44M | $2.24M |
| Shares outstanding | 391 | 2,285 |
| Cash flow statement | ||
| Operating cash flow | -$7.72M | -$14.35M |
| Capital expenditure | $61,000 | $141,000 |
| Free cash flow | -$7.78M | -$14.49M |
| Investing cash flow | -$505,000 | -$139,000 |
| Financing cash flow | $10.96M | $16.85M |
| Depreciation & amortization | $479,000 | $585,000 |
| Stock-based compensation | $421,000 | $380,000 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.